文献速递神经肿瘤

Ki-67增殖指数与颅内脑膜瘤复发风险:5050例多中心回顾性队列研究

The Ki-67 proliferation index and recurrence risk of intracranial meningioma: a multicenter, retrospective cohort study of 5,050 patients.
PubMed 文献 · Acta Neurochir (Wien) · 2026-04-06

该研究基于国际PERNS队列42个中心1989-2019年诊断的5050例颅内脑膜瘤患者,分析术后未接受放疗者Ki-67增殖指数与复发风险的关联。结果显示Ki-67的预后价值因WHO分级和Simpson切除分级而异,在Simpson 1-3级中WHO-2的预测准确性高于WHO-1,且随Simpson分级升高而增强,但Simpson 4级切除者无论WHO分级均无预测价值。

要点

  • Ki-67预后价值需结合WHO分级和切除程度解读。
  • Simpson 1-3级中WHO-2预测10年复发准确性高于WHO-1。
  • Simpson 4级切除者Ki-67无论WHO分级均无预测价值。

核心结论

  • Ki-67增殖指数应结合WHO分级和切除程度解读,可能有助于优化全切除患者术后10年内的个体化随访策略。
  • 研究结论不能外推至10年以上,尤其对低Ki-67的WHO-1级且Simpson 1级切除肿瘤。

研究设计与样本

  • 多中心回顾性队列研究,纳入国际PERNS队列42个中心1989-2019年诊断的5050例颅内脑膜瘤患者。
  • 患者均接受手术切除且术后未接受放疗,采用ROC分析评估Ki-67增殖指数术后10年内的预后准确性及其与复发风险的关联。

主要发现

  • Ki-67增殖指数的预后价值因WHO分级和Simpson分级定义的亚组而异。
  • 相同Simpson分级(1-3级)下,Ki-67对10年复发风险的预测准确性在WHO-2级中强于WHO-1级。
  • 在WHO-1级和WHO-2级脑膜瘤中,Ki-67的预测准确性随Simpson分级(1-3级)升高而增加。
  • Simpson 4级切除者无论WHO分级均未观察到Ki-67的预测价值。

临床怎么用

  • 对Simpson 1-3级切除的WHO-1或WHO-2级脑膜瘤,可结合Ki-67指数评估10年内复发风险以细化随访。
  • Simpson 4级切除者不应单独依据Ki-67指数判断复发风险。

局限性

  • 结论不能外推至术后10年以上,对低Ki-67的WHO-1级且Simpson 1级切除肿瘤尤其需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The Ki-67 proliferation index (Ki-67 PI) has been associated with meningioma recurrence, yet its clinical utility remains debated. Whether Ki-67 PI provides prognostic information across subgroups defined by both WHO grade and extent of resection remains to be investigated. METHODS: We analyzed 5,050 patients with intracranial meningiomas from the international PERNS cohort (42 centers, diagnosed between 1989-2019) who underwent surgical resection without postoperative radiotherapy. Ki-67 PI prognostic accuracy was assessed up to 10 years postoperatively by using ROC analyses and estimating its association with the risk of recurrence. RESULTS: Results demonstrated that the prognostic value of Ki-67 PI differed by subgroups defined by WHO grade and Simpson grade. For patients with the same Simpson grade (1-3), the predictive accuracy of Ki-67 PI for 10-year recurrence risk was stronger in WHO-2 than in WHO-1. Within WHO-1 and WHO-2 meningiomas, the predictive accuracy of Ki-67 PI increased with higher Simpson grade (1-3). However, no predictive value was observed in Simpson grade 4 resections regardless of WHO grade. CONCLUSION: These findings highlight that Ki-67 PI should be interpreted in the context of both WHO grade and extent of resection, and, if done so, may offer potential value to refine individualized surveillance strategies in meningioma patients with gross total resection in the initial 10-year postoperative timeframe. Findings cannot be extrapolated beyond 10 years, which may be particularly relevant for WHO-1 tumors with low Ki-67 PI and Simpson grade 1 resection.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Mirian C, Jensen LR, Juratli TA, et al. The Ki-67 proliferation index and recurrence risk of intracranial meningioma: a multicenter, retrospective cohort study of 5,050 patients. Acta Neurochir (Wien). 2026. PMID: 41942766. doi:10.1007/s00701-026-06846-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。